• Metronidazole: Applied OAT3 Inhibition & Microbiota Modul...

  2025-10-02

  Metronidazole stands out as more than a nitroimidazole antibiotic—its dual activity as a potent OAT3 inhibitor empowers innovative experimental designs in microbiota-immune modulation and drug-drug interaction studies. This guide delivers actionable workflows, troubleshooting strategies, and advanced applications to maximize research impact with Metronidazole.

• Metronidazole in Microbiota-Immune Modulation: A New Fron...

  2025-10-01

  Explore the unique potential of Metronidazole as a nitroimidazole antibiotic and OAT3 inhibitor in modulating the gut-immune axis and drug-drug interactions. This article delivers groundbreaking insights into Metronidazole’s advanced scientific applications for antibiotic research and immune signaling.

• Metronidazole: Beyond Antibiosis—A Systems Biology Lens o...

  2025-09-30

  Explore how Metronidazole, a nitroimidazole antibiotic and OAT3 inhibitor, uniquely bridges drug transport, microbiome modulation, and immune balance. This article synthesizes systems biology insights and highlights emerging research directions for advanced antibiotic and immunological studies.

• Metronidazole’s Dual Role: OAT3 Inhibition and Immune Pat...

  2025-09-29

  Explore the advanced applications of Metronidazole as both a nitroimidazole antibiotic and an OAT3 inhibitor. This article uniquely reveals how Metronidazole modulates immune signaling and drug transport, offering new perspectives for antibiotic research and drug-drug interaction studies.

• Metronidazole in Gut Microbiota and Immune Modulation Res...

  2025-09-28

  Explore the advanced role of Metronidazole as a nitroimidazole antibiotic, OAT3 inhibitor, and modulator of gut microbiota and immune signaling. This article delivers an in-depth, research-focused perspective distinct from standard antibiotic research reviews.

• Metronidazole as an OAT3 Inhibitor: Beyond Antibiotic Res...

  2025-09-27

  Explore the advanced role of Metronidazole as an OAT3 inhibitor in organic anion transporter modulation, with insights into drug-drug interactions and immune pathways. This article delivers unique scientific depth for researchers investigating anaerobic bacteria targeting and protozoa treatment mechanisms.

• N1-Methylpseudouridine: Next-Generation mRNA Modification...

  2025-09-26

  Explore how N1-Methylpseudouridine revolutionizes mRNA therapeutics research by enabling potent protein expression with reduced immunogenicity. This article uniquely examines its role in rescuing disease phenotypes, translational control, and future applications beyond current literature.

• Protease Inhibitor Cocktail EDTA-Free (100X): Precision T...

  2025-09-25

  Explore the advanced science of the Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) for protecting large protein complexes during extraction. Learn how this formulation empowers high-fidelity purification in plant and molecular systems, with technical insights beyond standard protocols.

• Protease Inhibitor Cocktail EDTA-Free: Transforming Advan...

  2025-09-24

  Explore how Protease Inhibitor Cocktail EDTA-Free (100X in DMSO) revolutionizes protein extraction and experimental fidelity in complex signaling and epigenetic studies. Discover unique insights into protease regulation, mRNA stability, and cutting-edge applications in reproductive biology.

• Annexin V as a Precision Apoptosis Assay Tool in Immune-I...

  2025-09-23

  Explore the advanced applications of Annexin V as a phosphatidylserine binding protein for sensitive apoptosis detection in immune cell research, with a focus on modeling immune dysregulation in diseases such as preeclampsia. This article details technical considerations and novel experimental strategies for leveraging Annexin V in complex cell death research.

• In large biopsies series from ALK NSCLC treated patients the

  2025-03-03

  

  In large biopsies series from ALK+ NSCLC treated patients, the number of detected mutations increased after second generation ALKi (Gainor et al., 2016) and in one study were present in 56% of the entire cohort (Shaw et al., 2013b). For example, the rate of G1202R mutations increases from 2% in post

• br Conclusion br Acknowledgement This work was supported by

  2025-03-03

  

  Conclusion Acknowledgement This work was supported by JSPS KAKENHI (Grant Number 15K18770). Introduction Neural crest deity tc 1 are multipotent progenitors in the vertebrate embryo that give rise to a vast array of different cell types including pigment cells, craniofacial skeleton and me

• br The AHR functions in the immune system a

  2025-03-03

  

  The AHR functions in the immune system – a tsunami of exciting findings The research of recent years has convincingly established an important function of the AHR in linking chemical environmental cues to immune responses [21,22], and reviewed in [1,23]. As a side effect, a view of the AHR as “Th

• A number of studies suggest that adiponectin promotes

  2025-03-03

  

  A number of studies suggest that adiponectin promotes osteoblast differentiation and bone formation by directly targeting GSK-3β and β-Catenin signaling [64], [65], favoring bone marrow mesenchymal stem cell (BMSC) differentiation toward the osteoblastic lineage [66], [67], decreasing sympathetic to

• A decrease in lactate concentration in

  2025-03-03

  

  A decrease in lactate concentration in the incubation medium was observed in samples treated with heparin and 2′,5′-dideoxyadenosine compared with the control (0.05; Fig. 2B). Discussion In the present study we compared the oxidative metabolism and intracellular signals of heparin, the glycosami

16378 records 1/1092 page Next 12345 下5页 Last page